Madrigal Share Price

Madrigal Share Price

NASDAQ: MDGL | Mid Cap | Healthcare
$396.59
-$0.57 (-0.14%) Last updated on 20 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Madrigal Stock Performance

Open
$401.19
Prev. Close
$397.16
Circuit Range
N/A
Day Range
$393.93 - $409.52
Year Range
$354.15 - $614.13
Volume
35,218
Average Traded
$398.95

Madrigal Share Price Today

As of 20 November 2026, Madrigal Pharmaceuticals, Inc.'s share price is $396.59. The stock opened at $401.19, compared to its previous close of $397.16. During today's trading session, Madrigal Pharmaceuticals, Inc.'s share price traded between $393.93 and $409.52, with an average price of $401.73. Over the past 52 weeks, the stock has recorded a high of $614.13 and a low of $354.15. In terms of performance, Madrigal Pharmaceuticals, Inc.'s share price has declined by 20.19% over the last six months and is down 33.58% on a year-on-year basis.

Madrigal Share Price Chart

Line chart of the Madrigal price trend over the selected period. The price fell overall, ranging from 393.77 to 422.18, ending at 398.35.
$393.93$409.52
L
Show Current Price
H

Madrigal Stock Fundamentals & Key Indicators

Market Cap
$8.90B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-6.69
Revenue (TTM)
$958.40B
Return On Equity (TTM)
-24.80%
Profit Margin
-30.08%
Debt to Equity
0.54
Quarterly Earnings Growth YoY
194.64%

Madrigal Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$321.08$311.34$364.25$431.27
Net Profit-$58.58-$94.39-$57.94$55.44
Net Profit Margin-18.24%-30.32%-15.91%12.86%
Income ChangeN/A-61.13%38.62%195.69%

Madrigal Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$180.13$958.40
Net Profit-$295.35-$373.63-$465.89-$288.28
Net Profit MarginN/AN/A-258.64%-30.08%
Income ChangeN/A-26.50%-24.69%38.12%

Madrigal Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets13.829.323.271.2
Current Assets1245.771032.93637.28361.37
Total Assets1259.591042.25640.55362.57
Non Current Liabilities346.61118.59116.6749.29
Current Liabilities310.29169.28118.55115.89
Total Liabilities656.9287.86235.21165.18
Shareholders' Equity602.69754.38405.33197.39

Madrigal Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-189.55-455.57-324.23-224.86
Investing32.32-274.39-502.52206.69
Financing255.98735.06595.12313.45

About Madrigal

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.

Madrigal Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$431.14
$396.30
-7.87%
Oct 2026
$503.21
$430.13
-14.62%
Sep 2026
$544.35
$503.77
-7.30%
Aug 2026
$468.70
$543.45
+16.19%
Jul 2026
$535.50
$467.72
-12.88%
Jun 2026
$494.44
$536.85
+8.03%
May 2026
$514.33
$496.94
-3.79%
Apr 2026
$544.66
$516.53
-1.27%
Mar 2026
$429.31
$523.17
+21.08%
Feb 2026
$486.09
$432.09
-11.58%
Jan 2026
$582.02
$488.67
-16.10%
Dec 2025
$591.94
$582.42
-2.46%

Madrigal Share Price FAQs